Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04762901
Title LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Antoinette Tan, MD
Indications

triple-receptor negative breast cancer

Therapies

Cyclophosphamide + Doxorubicin + Niraparib + Pegfilgrastim

Cyclophosphamide + Doxorubicin + Niraparib

Niraparib + Paclitaxel

Carboplatin + Niraparib + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.